| Current Price | $1.85 | Mkt Cap | $347.3M |
|---|---|---|---|
| Open | $1.83 | P/E Ratio | -3.16 |
| Prev. Close | $1.85 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $1.83 - $1.87 | Volume | 31,846 |
| 52-Wk Range | $1.08 - $3.43 | Avg. Daily Vol. | 71,098 |
| Current Price | $1.85 | Mkt Cap | $347.3M |
|---|---|---|---|
| Open | $1.83 | P/E Ratio | -3.16 |
| Prev. Close | $1.85 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $1.83 - $1.87 | Volume | 31,846 |
| 52-Wk Range | $1.08 - $3.43 | Avg. Daily Vol. | 71,098 |
The best Bull and Bear pitches based on recency and number of recommendations.
although viaskin didn't reach its PE of efficacy, the responder rates were still significant over placebo. There were no concerning TEAE's.. Viaskin's strong safety profile is what will put patients preference over AIMT's Ar101. AR101 experienced a… More
There are no pitches that meet the Top Bear criteria. Explain
If this upsets you, start recommending pitches below!
Read the most recent pitches from players about DBVT.
Recs
TMFSecurity
(93.18)
Submitted: 11/16/2021 9:59:49 AM :
Start Price:
$3.10
NASDAQ:DBVT Score:
+29.94
10000000146
Recs
MarkBiotech
(< 20)
Submitted: 3/7/2018 3:41:31 PM :
Start Price:
$22.21
NASDAQ:DBVT Score:
-146.27
although viaskin didn't reach its PE of efficacy, the responder rates were still significant over placebo. There were no concerning TEAE's.. Viaskin's strong safety profile is what will put patients preference over AIMT's Ar101. AR101 experienced a 12.4% discontinuation rate due to TEAE's meanwhile viaskin TEAE DR, was 1.1%. At the EOD, the patients are what matters the most. a risk of anaphylaxis is not something a parent will gamble with.. safety will always be the top priority when it comes to the parents choice for their kids. For that reason.. i'm going to go with viaskin as the SOC for peanut allergy resistance over AR101. Viaskin is also applicable in many other allergies including milk, nuts, egg.. Viaskin expansion of indications could easily put sales over 1b or a price of 100 PPS. PT-100.
Recs
stationfool
(69.00)
Submitted: 6/23/2015 1:09:32 PM :
Start Price:
$33.72
NASDAQ:DBVT Score:
-200.88
Peanut Allergy Drug
Find the members with the highest scoring picks in DBVT.
Bigcaps19 (93.03) Score: +132.69
The Score Leader is the player with the highest score across all their picks in DBVT.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| DyingClub | < 20 | 8/3/2020 |
|
5Y | $4.34 | -57.37% | +27.98% | +85.35 | 0 Comment | |
| Kinzo | 99.83 | 2/2/2021 |
|
5Y | $5.54 | -66.61% | +9.68% | +76.29 | 0 Comment | |
| TMFSecurity | 93.18 | 11/16/2021 |
|
NS | $3.10 | -40.32% | -10.38% | +29.94 | 1 Comment | |
| Narbly | < 20 | 10/2/2020 |
|
5Y | $1.72 | +7.56% | +26.69% | -19.13 | 0 Comment | |
| TSIF | 99.99 | 3/17/2020 |
|
1Y | $2.20 | -15.91% | +76.41% | -92.32 | 0 Comment | |
| vchelimella | < 20 | 5/29/2020 |
|
5Y | $4.84 | -61.78% | +39.15% | -100.92 | 0 Comment | |
| cashfoolery | 56.19 | 1/31/2020 |
|
5Y | $10.40 | -82.21% | +28.72% | -110.93 | 0 Comment | |
| portefeuille | 98.37 | 4/29/2019 |
|
5Y | $10.34 | -82.11% | +43.15% | -125.26 | 0 Comment | |
| northcutt0 | < 20 | 12/21/2018 |
|
5Y | $5.50 | -66.36% | +70.29% | -136.66 | 0 Comment | |
|
MarkBiotech | < 20 | 3/7/2018 |
|
5Y | $22.21 | -91.67% | +54.60% | -146.27 | 1 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
